March Biosciences

Focus: March Biosciences is a Houston-based biotechnology company focused on biologics and cell therapy, with active programs in gene therapy and cell therapy modalities. Company scale and financial details are not publicly available.

Gene Therapy Cell Therapy

Profile data last refreshed Yesterday · AI intelligence enriched 1w ago

Open Jobs

About March Biosciences

AI assessmentNot Hiring

No open roles listed right now. Follow March Biosciences to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthStrong

Pipeline

Late-stage

4 Phase 3+

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

TIME at Home

Mobility Limitation

N/A

Clinical Trials (1)

NCT06245135TIME™ at Home Randomized Controlled Trial

N/A

Help build intelligence for March Biosciences

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Pipeline spans Phase 3 programs (MB-105 in T-cell lymphoma, BNP7787 in breast cancer, Tavocept in NSCLC, Neonatal Kit in neurodevelopment) offering visibility into clinical advancement
Focused expertise in cell therapy and gene therapy represents high-growth therapeutic modalities with long-term market potential
Early-stage positioning provides opportunity to shape company direction and scale if pipeline programs succeed

Watch Out For

Zero active job openings and missing employee/funding data suggest company may be in stealth mode or early preclinical stage with limited hiring
Pipeline shows significant heterogeneity (educational programs, public health initiatives, dietary interventions mixed with drug programs), raising questions about focus and management discipline
No revenue, no recent news, no publications, and no patent cliff data creates uncertainty about operational maturity and go-to-market readiness

Generated by Claude from March Biosciences's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Stroke Caregiver Education and Support Program

Stroke

N/A

Clinical Trials (1)

NCT01355029Evaluation of the Stroke Caregiver Education and Support Program

N/A

Determinants of Fetal Inflammatory Exposure at Term

Maternal-Fetal Relations

N/A

Clinical Trials (1)

NCT00970151Determinants of Fetal Inflammatory Exposure at Term

N/A

Doula Model of Care

Perinatal

N/A

Clinical Trials (1)

NCT06915259Doula Model of Care

N/A

Maternal Gut Microbiome (MGM) Study of Diet, the Gut Microbiome and Preterm Birth

Preterm Birth

N/A

Clinical Trials (1)

NCT02560246Maternal Gut Microbiome (MGM) Study of Diet, the Gut Microbiome and Preterm Birth

N/A

Birth Cohort in Coast Province, Kenya

Mortality

N/A

Clinical Trials (1)

NCT02448615Birth Cohort in Coast Province, Kenya

N/A

CellulaR Injury and Preterm Birth

Preterm Birth

N/A

Clinical Trials (1)

NCT02441335CellulaR Injury and Preterm Birth

N/A

Lifestyle Counseling

Sudden Infant Death Syndrome

N/A

Clinical Trials (1)

NCT01361893Factors Influencing the Racial Disparity in Sudden Infant Death Syndrome (SIDS)

N/A

energy gel

Effect of Carbohydrate Ingestion During Active Labor

N/A

Clinical Trials (1)

NCT02642588Effect of a Commercially Available Carbohydrate Rich Gel on Maternal Fatigue: A Randomized Controlled Trial

N/A

Smoking Relapse Prevention

Smoking

N/A

Clinical Trials (1)

NCT01131156Prevention of Postpartum Smoking Relapse in Mothers of Infants in the Neonatal Intensive Care Unit (NICU)

N/A

Informed free choice

Pregnancy Related

N/A

OPV

Mortality

N/A

Clinical Trials (1)

NCT00625482Sex-Differential Health Interventions In Low-Birth-Weight Infants

N/A

Lysine Restricted Diet

Pyridoxine Dependant Epilepsy

N/A

Clinical Trials (1)

NCT01795170Neurodevelopmental Outcome of Early Dietary Lysine Restriction in Pyridoxine Dependent Epilepsy Patients

N/A

Healing @ Home Program

Depression, Postpartum

N/A

Clinical Trials (1)

NCT06877104Healing at Home 2.0 - Enhanced Chat Tool for Lowering Postpartum Depression

N/A

Aspirin 81 mg

Preeclampsia

N/A

MB-105

Any Patient Treated With MB-105

N/A

Clinical Trials (1)

NCT07340814A Long-term Follow-up Study of Patients Who Received MB-105

N/A

The Biomarker Study

Preterm Birth

N/A

Clinical Trials (1)

NCT01148654The Biomarker Study

N/A

Well Child Visits

Maternal Behavior

N/A

Clinical Trials (1)

NCT03024385Interconception Care at the University of Mississippi Medical Center

N/A

TIME™ at Home

Mobility Limitation

N/A

Clinical Trials (1)

NCT05369741TIME™ at Home Feasibility Study: Evaluation of a Virtually Delivered, Community-based, Task-oriented Exercise Program

N/A

Birth Cohort in Rahimyar Khan, Pakistan

Child Mortality

N/A

Clinical Trials (1)

NCT02233127Birth Cohort in Rahimyar Khan, Pakistan

N/A

Cognitive Processing Therapy

Post-traumatic Stress Disorder

N/A

Clinical Trials (1)

NCT01277354Effectiveness of Cognitive Processing Therapy in Pregnant Women With a History of Pregnancy Loss/Complication

N/A

PLAC1 in Reproduction

Pregnancy

N/A

Clinical Trials (1)

NCT01277848PLAC1 in Reproduction

N/A

Aspirin 81Mg Non-enteric coated Tab

Preeclampsia

Phase 1/2

N-acetylcysteine

Homocystinuria

Phase 2

Clinical Trials (1)

NCT00483314Homocystinuria: Treatment With N-Acetylcysteine

Phase 2

Genetic: MB-105

Lymphoma, T-Cell

Phase 2

Clinical Trials (1)

NCT06534060MB-105 in Patients With CD5 Positive T-cell Lymphoma

Phase 2

Neonatal kit

Neonatal Mortality

Phase 3

Clinical Trials (1)

NCT02130856Newborn Kit to Save Lives in Pakistan

Phase 3

Neonatal Kit

Neurodevelopment

Phase 3

Clinical Trials (1)

NCT02208960Newborn Kit to Save Lives and Brains in Kenya

Phase 3

BNP7787

Breast Neoplasms

Phase 3

Docosahexaenoic Acid + Arachidonic Acid

Preterm Birth

Phase 4

Clinical Trials (1)

NCT01576783Omega Tots: A Randomized, Controlled Trial of Long-chain Polyunsaturated Fatty Acid Supplementation of Toddler Diets and Developmental Outcomes

Phase 4

Vitamin A

Infant Mortality

Phase 4

Clinical Trials (1)

NCT00168610Vitamin A Supplementation With Bacille Calmette Guerin (BCG) Vaccine

Phase 4

Bacille Calmette Guerin

Tuberculosis

Phase 4

Clinical Trials (1)

NCT00146302Should Low Birth Weight Infants Be Vaccinated With BCG Vaccine at Birth in Developing Countries?